Data / Research funding / Mississippi / University of Mississippi Med CTR
University of Mississippi Med CTR: 120 NIH awards ($179.5M) and 1 NSF award ($230.6K), fiscal years 2021 to 2026
University of Mississippi Med CTR in Jackson, MS is funded under 120 NIH awards ($179.5M) and 1 NSF award ($230.6K) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- X59NJBFL8BJ3
- State
- Mississippi
Awards
121 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Mississippi Center for Clinical and Translational Research | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $18,674,548 | August 18, 2016 | July 31, 2026 | GRANGER, JOEY P. | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) FIELD CENTER (FC) - TASK AREA D | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $14,739,138 | August 13, 2023 | August 12, 2025 | CARSON, APRIL | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) COORDINATING CENTER (CC) - TASK AREA D | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $13,919,988 | August 13, 2023 | August 12, 2025 | CARSON, APRIL | reporter.nih.gov |
| Mississippi Center of Excellence in Perinatal Research, Phase 2 | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,229,000 | June 8, 2017 | May 31, 2027 | RECKELHOFF, JANE F | reporter.nih.gov |
| Molecular Center of Health and Disease | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $7,446,505 | March 6, 2023 | February 29, 2028 | GARRETT, MICHAEL R | reporter.nih.gov |
| Cardiorenal and Metabolic Diseases Research Center | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $5,037,364 | September 5, 2013 | April 30, 2023 | HALL, JOHN E | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,813,353 | January 15, 2025 | January 14, 2026 | WINDHAM, BEVERLY GWEN | reporter.nih.gov |
| A Proposal to Establish the Mississippi Violence Injury Prevention (VIP) Program | NIH | National Institute on Minority Health and Health Disparities | 2024 | $4,268,296 | September 15, 2022 | June 30, 2027 | ZHANG, LEI | reporter.nih.gov |
| Cardiorenal and Metabolic Diseases Research Center | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $3,987,500 | July 15, 2023 | June 30, 2028 | HALL, JOHN E | reporter.nih.gov |
| Jackson Heart Study (JHS) Field Center | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,819,327 | September 15, 2025 | September 14, 2026 | reporter.nih.gov | |
| JACKSON HEART STUDY (JHS) GRADUATE TRAINING AND EDUCATION CENTER (GTEC) - TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,682,352 | August 13, 2023 | August 12, 2025 | RENEKER, JENNIFER | reporter.nih.gov |
| The role of Pou4f3 in age-related vestibular dysfunction | NIH | National Institute on Aging | 2021 to 2025 | $3,193,066 | August 15, 2021 | April 30, 2026 | WALTERS, BRADLEY J. | reporter.nih.gov |
| Deterrents for prescription opioid abuse | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,853,877 | September 15, 2015 | May 31, 2027 | FREEMAN, KEVIN B. | reporter.nih.gov |
| Hypertension and Cardiorenal Research Training Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,818,763 | September 20, 2010 | August 31, 2030 | GRANGER, JOEY P. | reporter.nih.gov |
| Balance and Auditory Research Center (BARC) | NIH | National Institute of General Medical Sciences | 2025 | $2,624,974 | September 1, 2025 | July 31, 2030 | ZHOU, WU | reporter.nih.gov |
| Mechanisms of Blast-Induced Vestibular Injury | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2024 | $2,459,906 | September 11, 2020 | August 31, 2025 | ZHU, HONG | reporter.nih.gov |
| Mechanism of PD1 on cardiac inflammation resolution during heart failure development | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,306,775 | February 1, 2022 | January 31, 2027 | CHEN, YINGJIE | reporter.nih.gov |
| Endothelin-1 in Obesity and Insulin Resistance | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,172,603 | April 9, 2021 | January 31, 2026 | SPEED, JOSHUA S | reporter.nih.gov |
| MS-ISPCTN (Cycle 3) | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $2,131,128 | September 23, 2016 | May 31, 2030 | MAJURE, JOSEPH MARC | reporter.nih.gov |
| Water Contaminants and Cardiovascular Risk: the Jackson Heart Study | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,087,529 | September 1, 2024 | July 31, 2028 | CARSON, APRIL P | reporter.nih.gov |
| Benzodiazepine Choice and Polydrug Use | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,074,200 | April 1, 2022 | January 31, 2027 | HUSKINSON, SALLY L | reporter.nih.gov |
| GABA-A receptor subtype mechanisms and the abuse-related effects of alcohol | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $1,892,872 | September 15, 2020 | July 31, 2026 | PLATT, DONNA M | reporter.nih.gov |
| Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment | NIH | National Institute on Drug Abuse | 2021 to 2025 | $1,872,481 | June 1, 2002 | February 29, 2028 | ROWLETT, JAMES K | reporter.nih.gov |
| Anti-Inflammatory Roles and Macrophage Metabolism of Lactate and Ketones during Myocardial Infarction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,789,958 | August 11, 2023 | July 31, 2028 | MOUTON, ALAN J | reporter.nih.gov |
| Cardiac protective mechanisms of melanocortin system activation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,747,424 | January 9, 2023 | December 31, 2026 | SILVA, ALEXANDRE ALVES DA | reporter.nih.gov |
| Vascular mechanisms of inhibition of sEH as a novel therapy for AD/ADRD | NIH | National Institute on Aging | 2022 | $1,720,413 | August 15, 2022 | July 31, 2025 | ROMAN, RICHARD J. | reporter.nih.gov |
| A Novel Protein Delivery System for Therapy of Preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,698,755 | January 15, 2014 | March 31, 2026 | BIDWELL, GENE LEFLORE | reporter.nih.gov |
| Anxiolytic Effects and Abuse of BZ Receptor Ligands | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,607,424 | June 15, 1998 | April 30, 2026 | ROWLETT, JAMES K | reporter.nih.gov |
| Diurnal Molecular Rhythms of the Human Hypothalamus and Involvement in Bipolar Disorder | NIH | National Institute of Mental Health | 2021 to 2024 | $1,581,638 | September 20, 2021 | August 31, 2025 | PANTAZOPOULOS, HARRY | reporter.nih.gov |
| Endothelial PHD2 in hypertensive vascular remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,550,000 | September 1, 2021 | December 31, 2025 | CHEN, JIAN-XIONG | reporter.nih.gov |
| Hypertension, Inflammation, and Vascular Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,535,700 | May 19, 2020 | March 31, 2026 | CORNELIUS, DENISE CRESHUN | reporter.nih.gov |
| Fentanyl use during pregnancy: impact on dam, placenta, and offspring development. | NIH | National Institute on Drug Abuse | 2023 | $1,509,492 | August 1, 2023 | July 31, 2026 | RÜEDI-BETTSCHEN, DANIELA | reporter.nih.gov |
| Short Sleep Duration as a Predictor of Methamphetamine Intake: Role of Orexin Mechanisms | NIH | National Institute on Drug Abuse | 2024 to 2025 | $1,492,883 | July 15, 2024 | April 30, 2029 | BERRO, LAIS F | reporter.nih.gov |
| Integrative Role of Bilirubin on Obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,491,651 | April 1, 2020 | January 31, 2025 | STEC, DAVID E | reporter.nih.gov |
| Causes of Sex Differences in male and female offspring born from inflammation mediated hypertensive pregnancy | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,482,650 | August 15, 2025 | July 31, 2030 | LAMARCA, BABBETTE | reporter.nih.gov |
| Mechanisms responsible for tooth morphogenesis in vertebrates | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $1,423,153 | August 2, 2021 | June 30, 2025 | GIBERT, YANN | reporter.nih.gov |
| A Proposal to Establish the Mississippi Violence Injury Prevention (VIP) Program | NIH | National Institute on Minority Health and Health Disparities | 2022 | $1,385,082 | September 15, 2022 | June 30, 2024 | ZHANG, LEI | reporter.nih.gov |
| Role of obesity in blood pressure regulation and insulin resistance in Polycystic Ovary Syndrome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,368,130 | December 1, 2023 | November 30, 2028 | YANES CARDOZO, LICY LORENA | reporter.nih.gov |
| Mechanisms of transition from acute to chronic pain in Non-Hispanic Black and White injury patients | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2023 | $1,349,929 | September 11, 2022 | June 30, 2023 | MORRIS, MATTHEW C. | reporter.nih.gov |
| Identifying Novel Biological Pathways for Gout using DNA Methylation and Genetics | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,218,051 | September 21, 2018 | November 30, 2023 | TIN, ADRIENNE | reporter.nih.gov |
| Degenerin and TrpC6 channels in renal vascular mechanosesnsor signaling and protection against injury. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,209,764 | April 1, 2024 | March 31, 2028 | DRUMMOND, HEATHER A | reporter.nih.gov |
| Adducin, actin cytoskeleton and cognitive impairments | NIH | National Institute on Aging | 2021 to 2023 | $1,162,500 | April 1, 2019 | January 31, 2025 | WILLIAMS, JAN MICHAEL | reporter.nih.gov |
| Design Optimization of Reduced-Diameter Implants in Simulated and Cadaver Bone | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,084,580 | April 1, 2019 | March 31, 2026 | GRIGGS, JASON A | reporter.nih.gov |
| Sex differences in hypertension, cognitive function and renal hemodynamics; a role for B cells and autoantibodies | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,002,100 | June 1, 2024 | May 31, 2028 | LAMARCA, BABBETTE | reporter.nih.gov |
| Southeast Center for Health Achievement and Growth in Equity (SEACHANGE) Hub | NIH | National Cancer Institute | 2024 | $948,531 | September 6, 2024 | April 7, 2025 | COMPRETTA, CAROLINE E. | reporter.nih.gov |
| Hypertension in Adult IUGR Offspring: Beneficial Effects of Perinatal Intervention | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $918,732 | December 1, 2019 | November 30, 2024 | ALEXANDER, BARBARA T | reporter.nih.gov |
| Childrens' of Mississippi Neonatal Research Group | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $895,767 | April 1, 2023 | March 31, 2030 | BHATT, ABHAY J | reporter.nih.gov |
| Initiation of immune responses to SARS COV2 in the oral cavity and upper airway | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2023 | $822,037 | April 1, 2022 | April 30, 2023 | GLOVER, SARAH C | reporter.nih.gov |
| The oxidation of heme-carrying proteins in the pathophysiology of pneumococcal disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $805,442 | November 20, 2023 | October 31, 2028 | VIDAL, JORGE EUGENIO | reporter.nih.gov |
| IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 | $790,319 | November 15, 2016 | November 14, 2021 | MOSLEY, THOMAS H | reporter.nih.gov |
| MIF and Cardiovascular Inflammation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $761,250 | July 15, 2021 | June 30, 2025 | LI, JI | reporter.nih.gov |
| Improving Hypertension Treatment in African Americans Using Computational Modeling and Predictive Analytics | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2024 | $747,000 | September 23, 2020 | April 30, 2026 | CLEMMER, JOHN S | reporter.nih.gov |
| Immune system dysfunction and gut dysbiosis in the pathogenesis of vascular dysfunction in autoimmunity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $747,000 | January 5, 2022 | December 31, 2024 | TAYLOR, ERIN BASSFORD | reporter.nih.gov |
| Sex Differences in Addiction | NIH | National Institute on Drug Abuse | 2022 to 2024 | $747,000 | March 1, 2019 | February 28, 2026 | KOHTZ, AMY | reporter.nih.gov |
| Role of orexin receptors in the abuse- and sleep-related effects of methamphetamine | NIH | National Institute on Drug Abuse | 2022 to 2024 | $747,000 | August 1, 2020 | July 31, 2026 | BERRO, LAIS F | reporter.nih.gov |
| Unpredictable availability as a determinant of drug-related outcomes | NIH | National Institute on Drug Abuse | 2021 to 2022 | $736,250 | April 1, 2018 | March 31, 2025 | HUSKINSON, SALLY | reporter.nih.gov |
| Dissecting roles of Lunatic Fringe-dependent Notch signaling in pancreatic cancer | NIH | National Cancer Institute | 2024 to 2025 | $709,126 | May 1, 2024 | April 30, 2029 | XU, KELI | reporter.nih.gov |
| Multivalent antibody cocktail for bacterial endophthalmitis | NIH | National Eye Institute | 2025 | $693,423 | September 15, 2025 | August 31, 2026 | MARQUART, MARY E | reporter.nih.gov |
| Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $637,500 | July 23, 2019 | June 30, 2025 | GOMEZ-SANCHEZ, CELSO ENRIQUE | reporter.nih.gov |
| Mitochondrial DNA in the pathogenesis of post-injury coagulopathy | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $624,570 | August 1, 2020 | July 31, 2025 | KUTCHER, MATTHEW E | reporter.nih.gov |
| Novel liver-mediated mechanisms in hypertension and cardiac dysfunction | NIH | National Heart, Lung, and Blood Institute | 2025 | $604,818 | May 15, 2025 | February 28, 2029 | STEC, DAVID E | reporter.nih.gov |
| Activated Protein C Signaling in Aging | NIH | National Institute on Aging | 2024 | $575,667 | August 1, 2024 | April 30, 2029 | LI, JI | reporter.nih.gov |
| Polydrug Abuse: Opioid-Alcohol Combinations | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $571,673 | September 23, 2025 | July 31, 2030 | PLATT, DONNA M | reporter.nih.gov |
| Vascular mechanisms of inhibition of sEH as a novel therapy for AD/ADRD | NIH | National Institute on Aging | 2025 | $561,470 | August 15, 2022 | July 31, 2027 | ROMAN, RICHARD J. | reporter.nih.gov |
| Mechanisms of Treg and IL-35 in Regulating LV Failure-induced Lung Remodeling and Right Heart Hypertrophy | NIH | National Heart, Lung, and Blood Institute | 2021 | $549,819 | July 1, 2018 | May 31, 2024 | CHEN, YINGJIE | reporter.nih.gov |
| Brain MC4R-BAT-Heart crosstalk: a potential new therapeutic target for myocardial ischemia/reperfusion injury | NIH | National Heart, Lung, and Blood Institute | 2025 | $540,927 | September 1, 2025 | June 30, 2030 | OMOTO, ANA CAROLINA MIEKO | reporter.nih.gov |
| Genetic determinants of hypertension-induced cerebral vascular dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 | $486,423 | March 1, 2018 | January 31, 2024 | ROMAN, RICHARD J. | reporter.nih.gov |
| Investigating Socio-Structural Determinants of Health and the Tumor Epigenome to Understand the Etiology of Racial Disparities in Breast Cancer | NIH | National Cancer Institute | 2024 to 2025 | $484,202 | March 11, 2022 | January 31, 2027 | MILLER-KLEINHENZ, JASMINE | reporter.nih.gov |
| Mobility Decline: Relations to Cerebral Perfusion, Small Vessel Disease Progression, and Longitudinal Blood Pressure Exposures | NIH | National Institute on Aging | 2021 | $480,507 | September 15, 2018 | March 31, 2025 | WINDHAM, BEVERLY GWEN | reporter.nih.gov |
| HEMOGLOBIN-INDUCED VIRULENCE IN STREPTOCOCCUSPNEUMONIAE | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $441,005 | March 10, 2021 | February 29, 2024 | VIDAL, JORGE EUGENIO | reporter.nih.gov |
| Consequences of fentanyl self-administration during pregnancy | NIH | National Institute on Drug Abuse | 2021 to 2022 | $426,250 | April 1, 2021 | March 31, 2024 | RÜEDI-BETTSCHEN, DANIELA | reporter.nih.gov |
| Host genetic variation affecting the microbiome in rhesus macaques | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $426,250 | July 15, 2021 | June 30, 2025 | VALLENDER, ERIC J. | reporter.nih.gov |
| Modeling the Emergence of MRSA Strains | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $426,250 | August 19, 2021 | July 31, 2024 | ROBINSON, DAVID ASHLEY | reporter.nih.gov |
| Ear Level Cooling for Otoprotection | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2023 | $426,250 | March 1, 2022 | February 28, 2025 | SPANKOVICH, CHRISTOPHER | reporter.nih.gov |
| Orexin Signaling in the Mouse Cochlea | NIH | National Institute on Deafness and Other Communication Disorders | 2023 to 2024 | $426,250 | December 1, 2022 | November 30, 2025 | VETTER, DOUGLAS E | reporter.nih.gov |
| Mechanisms underlying adhesion and colonization in pneumococcal keratitis | NIH | National Eye Institute | 2023 | $426,250 | August 1, 2023 | July 31, 2025 | MARQUART, MARY E | reporter.nih.gov |
| Upgrade to Housing Systems for Nonhuman Primates in the Center for Comparative Research | NIH | Office of the Director, National Institutes of Health | 2022 | $396,500 | June 1, 2022 | May 31, 2024 | GRADY, ANDREW W | reporter.nih.gov |
| Mechanisms of Seizure in Pregnancy and Preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2021 | $389,514 | September 20, 2021 | August 31, 2023 | WARRINGTON, JUNIE PAULA | reporter.nih.gov |
| Molecular Basis of Postischemic Maladaptation in the Insulin Resistant Heart | NIH | National Heart, Lung, and Blood Institute | 2021 | $387,500 | April 1, 2018 | February 25, 2022 | HARMANCEY, ROMAIN | reporter.nih.gov |
| Genetic Targets of Hypertension End Organ Damage | NIH | National Heart, Lung, and Blood Institute | 2021 | $387,500 | September 6, 2018 | June 30, 2023 | GARRETT, MICHAEL R | reporter.nih.gov |
| P53 acetylation in microvascular rarefaction and heart failure | NIH | National Heart, Lung, and Blood Institute | 2022 | $387,500 | September 23, 2022 | August 31, 2024 | ZENG, HENG | reporter.nih.gov |
| Mechanisms of Cardiorenal Disease following Preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2021 | $381,250 | January 1, 2017 | December 31, 2022 | GARRETT, MICHAEL R | reporter.nih.gov |
| A Novel Therapy For Preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2021 | $381,250 | July 1, 2017 | June 30, 2022 | GEORGE, ERIC MATTHEW | reporter.nih.gov |
| Impact of social factors on breast cancer biology in African-American women | NIH | National Cancer Institute | 2023 | $354,207 | July 1, 2019 | June 30, 2026 | SINGH, SEEMA | reporter.nih.gov |
| Mechanisms involved in the early development of renal disease associated with prepubertal obesity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $348,750 | June 13, 2017 | April 30, 2023 | WILLIAMS, JAN MICHAEL | reporter.nih.gov |
| Molecular determinants of cell fate in the inner ear | NIH | National Institute on Deafness and Other Communication Disorders | 2021 | $324,063 | July 1, 2017 | June 30, 2023 | WALTERS, BRADLEY J. | reporter.nih.gov |
| Prototype Mouse Models for SEND-Based mRNA Delivery and Technology Development | NIH | National Institute of General Medical Sciences | 2025 | $322,229 | September 18, 2024 | June 30, 2028 | GURUMURTHY, CHANNABASAVAIAH | reporter.nih.gov |
| Platelet-mediated mechanisms of placental and systemic hypercoagulability in preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $319,182 | August 20, 2022 | July 31, 2025 | PALEI, ANA CAROLINA | reporter.nih.gov |
| Novel primer for bonding and debonding of high-strength dental ceramics | NIH | National Institute of Dental & Craniofacial Research | 2024 | $310,000 | September 20, 2024 | September 19, 2026 | SALAZAR MAROCHO, SUSANA M | reporter.nih.gov |
| Long-term consequences of parental obesity on developmental programming of cardiorenal diseases in offspring | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $272,500 | September 19, 2019 | July 31, 2023 | DO CARMO, JUSSARA M. | reporter.nih.gov |
| Mississippi Diversity in Hypertension and Cardiorenal Research Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $268,273 | April 1, 2014 | March 31, 2026 | TAYLOR, ERIN BASSFORD | reporter.nih.gov |
| Collaborative Research: E-RISE RII: Establishment of the Mississippi Nano-bio and ImmunoEngineering Consortium | NSF | Office of Integrative Activities | 2024 | $230,574 | August 1, 2024 | July 31, 2028 | Amol V Janorkar | nsf.gov |
| Characterization of viridans group streptococci from endophthalmitis | NIH | National Eye Institute | 2021 | $225,525 | September 1, 2020 | August 31, 2023 | MARQUART, MARY E | reporter.nih.gov |
| Obesity Health Disparities Research PRIDE Program (OHD PRIDE) | NIH | National Heart, Lung, and Blood Institute | 2021 | $210,847 | September 15, 2014 | July 31, 2021 | BRUCE, MARINO A | reporter.nih.gov |
| Insulin and Immune Mechanisms in Obesity-Induced Renal Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $200,000 | September 5, 2024 | August 31, 2025 | WILLIAMS, JAN MICHAEL | reporter.nih.gov |
| An Artificial Eggshell Membrane for Guided Tissue Regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 | $155,000 | May 1, 2020 | October 31, 2022 | DUAN, YUANYUAN | reporter.nih.gov |
| Graduate Training in Neuroscience at the University of Mississippi Medical Center | NIH | National Institute of Mental Health | 2025 | $142,893 | September 1, 2025 | August 31, 2030 | WARRINGTON, JUNIE PAULA | reporter.nih.gov |
| Alcohol-induced decreases in REM sleep: GABA-A receptor subtypes | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $140,482 | June 1, 2021 | May 31, 2024 | REEVES-DARBY, JAREN ASHER | reporter.nih.gov |
| Role of orexin receptors in the abuse- and sleep-related effects of methamphetamine | NIH | National Institute on Drug Abuse | 2021 | $126,997 | August 1, 2020 | July 31, 2022 | BERRO, LAIS F | reporter.nih.gov |
| An MMP-2 Inhibitory Biologic for Treatment of Renal Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $121,282 | August 15, 2021 | August 14, 2024 | AKINLEYE, ADESANYA ABISOLA | reporter.nih.gov |
| Investigation of in vivo efficacy of G-protein biased mu opioid receptor agonists. | NIH | National Institute on Drug Abuse | 2022 to 2024 | $119,510 | April 1, 2022 | March 31, 2025 | PHAM, LOC M | reporter.nih.gov |
| Immune system dysfunction and gut dysbiosis in the pathogenesis of vascular dysfunction in autoimmunity | NIH | National Heart, Lung, and Blood Institute | 2021 | $101,529 | January 1, 2020 | December 31, 2021 | TAYLOR, ERIN BASSFORD | reporter.nih.gov |
| Improving Hypertension Treatment in African Americans Using Computational Modeling and Predictive Analytics | NIH | National Institute on Minority Health and Health Disparities | 2021 | $101,117 | September 23, 2020 | April 30, 2022 | CLEMMER, JOHN S | reporter.nih.gov |
| Role of sleep disruption in cognitive impairment associated with methamphetamine use | NIH | National Institute on Drug Abuse | 2024 to 2025 | $98,512 | April 2, 2024 | April 1, 2027 | BORGATTI, DANIEL | reporter.nih.gov |
| The role of IL-33 signaling in the pathophysiology of preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $78,628 | August 15, 2022 | August 14, 2024 | WANG, XI | reporter.nih.gov |
| Coilin is a Mediator of m6A RNA Methylation | NIH | National Institute of General Medical Sciences | 2023 to 2024 | $77,829 | March 17, 2023 | August 16, 2024 | MCLAURIN, DOUGLAS | reporter.nih.gov |
| Impact of SGLT-2 Inhibition on the Cardiometabolic Profile of PCOS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $76,498 | March 1, 2021 | February 28, 2023 | PRUETT, JACOB E | reporter.nih.gov |
| B Cells in Preeclampsia: Long-term Effects on Offspring | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $75,052 | April 11, 2025 | April 10, 2028 | CAMPBELL, NATHAN E. | reporter.nih.gov |
| Roles of DPA derived specialized pre-resolving mediators during vertebrate hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $64,668 | September 1, 2023 | August 31, 2025 | NGUYEN, KIM UYEN | reporter.nih.gov |
| Behavioral Pharmacology of Injury Restricted Fentanyl Analogues. | NIH | National Institute on Drug Abuse | 2022 to 2024 | $62,446 | December 3, 2022 | December 2, 2024 | EDWARDS, SHELLEY R | reporter.nih.gov |
| The Role of the Extracellular Matrix in Alcohol Use Disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2024 | $56,545 | April 20, 2023 | May 31, 2024 | VALERI, JAKE RYAN | reporter.nih.gov |
| The Role of AT1-AA in Causing Adult Hypertension in Offspring Born with FGR | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $48,045 | September 14, 2022 | March 3, 2024 | CAMPBELL, NATHAN E. | reporter.nih.gov |
| The use of a biopolymer-fused form of VEGF-B for the treatment of Preeclampsia. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $47,022 | March 2, 2020 | May 27, 2022 | WALLER, JAMARIUS | reporter.nih.gov |
| Role of Endocannabinoid System in Seizure Sensitivity in Eclampsia | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $41,352 | July 1, 2022 | June 30, 2023 | JONES-MUHAMMAD, MARIA AISHA | reporter.nih.gov |
| The Role of 20-HETE in the Pathogenesis of Dementia | NIH | National Institute on Aging | 2021 | $39,691 | June 1, 2020 | May 31, 2022 | GONZALEZ-FERNANDEZ, EZEKIEL | reporter.nih.gov |
| Transcriptional differences in human postmortem brain tissue correspond with impulsive behavior in mood disorders | NIH | National Institute of Mental Health | 2025 | $39,000 | July 17, 2025 | July 16, 2027 | PERSON, JON | reporter.nih.gov |
| Cross Sex Steroid Therapy and Cardiovascular Risk in the Transgender Female | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $35,098 | December 1, 2023 | March 3, 2025 | CRUDUP, BRELAND | reporter.nih.gov |
| AHA Hypertension Scientific Sessions | NIH | National Heart, Lung, and Blood Institute | 2024 | $22,500 | August 1, 2024 | July 31, 2025 | RECKELHOFF, JANE F | reporter.nih.gov |
| Hypertension Scientific Sessions 2025 | NIH | National Heart, Lung, and Blood Institute | 2025 | $15,000 | September 1, 2025 | August 31, 2026 | RECKELHOFF, JANE F | reporter.nih.gov |
| Therapeutic selectivity of biased mu-opioid agonists. | NIH | National Institute on Drug Abuse | 2021 | $13,490 | April 2, 2019 | June 30, 2021 | ZAMARRIPA, CARLOS AUSTIN | reporter.nih.gov |
| A Role for Natural Killer Cells in the Development of Intrauterine Growth Restriction and Hypertension During Pregnancy | NIH | National Heart, Lung, and Blood Institute | 2021 | $11,882 | April 1, 2020 | May 31, 2021 | TRAVIS, OLIVIA KRISTELL | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 1 | $76,858 |
| 2025 | 40 | $32,954,209 | 0 | $0 |
| 2024 | 54 | $35,039,581 | 1 | $153,716 |
| 2023 | 54 | $46,664,813 | 0 | $0 |
| 2022 | 56 | $32,495,021 | 0 | $0 |
| 2021 | 58 | $32,326,814 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 2 awards here | |
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) | PA-25-080 | NIH | September 7, 2027 | Not listed | Notice number printed on 1 award here | |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.837 | December 3, 2026 | Not listed | Same assistance listing 93.837 as 32 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.837 | December 3, 2026 | Not listed | Same assistance listing 93.837 as 32 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.837 | December 4, 2026 | Not listed | Same assistance listing 93.837 as 32 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.837 | January 5, 2027 | Not listed | Same assistance listing 93.837 as 32 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.837 | January 5, 2027 | Not listed | Same assistance listing 93.837 as 32 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.837 | January 7, 2027 | $375,000 | Same assistance listing 93.837 as 32 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.837 | January 7, 2027 | Not listed | Same assistance listing 93.837 as 32 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) | PAR-25-025 | NIH | 93.837 | February 3, 2027 | $1.5 million | Same assistance listing 93.837 as 32 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) | PAR-25-026 | NIH | 93.837 | February 3, 2027 | Not listed | Same assistance listing 93.837 as 32 awards here |
| Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) | PAR-27-125 | NIH | 93.837 | February 16, 2027 | Not listed | Same assistance listing 93.837 as 32 awards here |
| Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) | RFA-DK-27-108 | NIH | 93.837 | March 10, 2027 | $500,000 | Same assistance listing 93.837 as 32 awards here |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) | PAR-25-032 | NIH | 93.837 | March 16, 2027 | Not listed | Same assistance listing 93.837 as 32 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.837 | April 5, 2027 | Not listed | Same assistance listing 93.837 as 32 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.837 | April 5, 2027 | Not listed | Same assistance listing 93.837 as 32 awards here |
| Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) | RFA-OD-25-003 | NIH | 93.837 | April 9, 2027 | $200,000 | Same assistance listing 93.837 as 32 awards here |
| NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) | RFA-HL-26-002 | NIH | 93.837 | April 28, 2027 | Not listed | Same assistance listing 93.837 as 32 awards here |
| NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) | RFA-HL-26-003 | NIH | 93.837 | April 28, 2027 | Not listed | Same assistance listing 93.837 as 32 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) | PA-24-175 | NIH | 93.837 | May 7, 2027 | Not listed | Same assistance listing 93.837 as 32 awards here |
Topics of its NIH awards
- Cardiovascular
- Neurosciences
- Hypertension
- Prevention
- Brain Disorders
- Behavioral and Social Science
- Clinical Research
- Pediatric
- Genetics
- Substance Misuse
- Aging
- Women's Health
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.